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Abstract
Salmonella enterica is commonly acquired from contaminated food and is an important cause of illness world-
wide. Interventions are needed to control Salmonella; subtyping Salmonella by serotyping is useful for targeting
such interventions. We, therefore, analyzed the global distribution of the 15 most frequently identified serovars
of Salmonella isolated from humans from 2001 to 2007 in laboratories from 37 countries that participated in
World Health Organization Global Foodborne Infections Network and demonstrated serotyping proficiency in
the Global Foodborne Infections Network External Quality Assurance System. In all regions throughout the
study period, with the exception of the Oceania and North American regions, Salmonella serovars Enteritidis and
Typhimurium ranked as the most common and second most common serovar, respectively. In the North
American and Oceania (Australia and New Zealand) regions, Salmonella serovar Typhimurium was the most
common serovar reported, and Salmonella serovar Enteritidis was the second most common serovar. During the
study period, the proportion of Salmonella isolates reported from humans that were Salmonella serovar Enteritidis
was 43.5% (range: 40.6% [2007] to 44.9% [2003]), and Salmonella serovar Typhimurium was 17.1% (range: 15%
[2007] to 18.9% [2001]). Salmonella serovars Newport (mainly observed in Latin and North American and
European countries), Infantis (dominating in all regions), Virchow (mainly observed in Asian, European, and
Oceanic countries), Hadar (profound in European countries), and Agona (intense in Latin and North American
and European countries) were also frequently isolated with an overall proportion of 3.5%, 1.8%, 1.5%, 1.5%, and
0.8%, respectively. There were large differences in the most commonly isolated serovars between regions, but
lesser differences between countries within the same region. The results also highlight the complexity of the
global epidemiology of Salmonella and the need and importance for improving monitoring data of those serovars
of highest epidemiologic importance.
Introduction
Salmonella enterica is commonly acquired from con-taminated food and is a common cause of human gastro-
enteritis and bacteraemia worldwide. It is estimated that
Salmonella causes 93.8 million human infections and 155,000
deaths annually worldwide (Majowicz et al., 2010). A wide
variety of animals, particularly food animals, have been
identified as reservoirs for nontyphoidal Salmonella (Cray
et al., 2000; Uzzau et al., 2000; Pires et al., 2009).
Although > 2500 serovars of S. enterica have been identi-
fied,most human infections are caused by a limited number of
serovars ( Jones et al., 2008). In most developed countries, S.
enterica serovars Typhimurium and Enteritidis are the most
commonly reported causes of human salmonellosis; however,
other serovars appear to be more prevalent in specific regions
such as Salmonella serovar Stanley and Salmonella serovar
Weltevreden in Southeast Asia (Olsen et al., 2001; Herikstad
et al., 2002; Bangtrakulnonth et al., 2004; Galanis et al., 2006;
Hendriksen et al., 2009a). Shifts in the prevalence of specific
strain types and serovars in human and animal populations
may follow the introduction of the strain through interna-
tional travel, human migration, food, animal feed, and live-
stock trade (Clark et al., 1973; Crump et al., 2002; Aarestrup
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et al., 2007; Hendriksen et al., 2008; Ethelberg et al., 2010). Thus,
failure to control Salmonella in one country presents a potential
problem for other countries. To minimize the burden of this
pathogen, it is helpful to monitor Salmonella serovar distri-
bution in many countries, implement Salmonella control
measures throughout the food production chain, and monitor
the effectiveness of the control measures.
In January 2000, the World Health Organization (WHO)
launched the WHO Global Salm-Surv program, now known
as the WHO Global Foodborne Infections Network (GFN), a
global effort to build capacity to detect, control, and prevent
foodborne and other enteric infections from farm to table. A
key objective of GFN is to enhance laboratory-based surveil-
lance worldwide by improving laboratory capacity for ser-
otyping of Salmonella. This objective is facilitated by bench-top
training at international courses and workshops.
Laboratories participating in the GFN program are en-
couraged to annually report the 15 most frequently isolated
Salmonella serovars via an Internet-based country data bank
(CDB). This database is available online (www.who.int/gfn/
en/). Laboratories participating in the GFN program are also
encouraged to participate in activities aimed at strengthening
laboratory quality management systems, including partici-
pation in an annual proficiency test: External Quality Assur-
ance System (EQAS), which was established in 2000 (Petersen
et al., 2002; Hendriksen et al., 2009b, c).
To assist national and international efforts aimed at control
of Salmonella, we analyzed the distribution of the most prev-
alent Salmonella serovars from 2001 to 2007 reported from
participating laboratories that demonstrated high-quality
serotyping capability.
Materials and Methods
Country data bank
The CDB is a Web-enabled Oracle database. Only autho-
rized members may enter data into the CDB and data entry is
password-protected. However, the CDB may be viewed and
queried by the general public. Each year, a designated repre-
sentative for each laboratory is requested to enter the number
of Salmonella isolated from human, animal, food, environ-
mental, and/or feed sources and the number of the top 15most
frequently identified serovars from each of these sources.
From 2000 to 2009, a total of 790 national data sets from
national reference laboratories and 158 institutional data sets
covering all of the sources were uploaded into the CDB, of
which 621 national data sets and 135 institutional data sets
were submitted from 2001 to 2007. To prevent duplication, if
national data were available from an institution, data from
institutions in that country were excluded. This leave 273
national data sets and 53 institutional data sets; 148 from
Europe, 38 from Asia, 13 from Oceania, 35 from Africa, 11
from North America, and 81 from Latin America contained
results from isolates from humans.
External Quality Assurance System
The EQAS is described, in detail, elsewhere (Petersen et al.,
2002; Hendriksen et al., 2009b). Participating laboratories are
requested to serotype eight Salmonella test isolates and submit
their results through a password-protected database to the
WHO Collaborating Centre for Antimicrobial Resistance in
Foodborne Pathogens, Copenhagen, Denmark (the coordinat-
ing laboratory). The participants then instantly obtain an eval-
uation report with suggestions for corrective actions. The data
are stored centrally, summarized, and an annual report is pub-
lished online www.who.int/gfn/activities/GSS_EQAS/en/.
During 2001–2007, a total of 294 laboratories in 107 countries
participated in the serotyping component of the EQAS. A total
of 150 laboratories in 61 countries met the EQAS threshold
(eight isolates tested with a maximum of one deviation from
the expected serotyping result) from 2001 to 2007.
Only data from members who had uploaded summarized
data of human origin into the CDB, and met the EQAS
threshold in one or more iterations of the EQASwere included
in the analysis. We wanted to explore the member data from
each country; number of Salmonella isolated and serotyped as
well as the top 15 most common serovars from human isolates
over time; and every second year from 2001 to 2007where data
were available. For easy of analysis and interpretation, we
confined the analysis to every other year: from2001 to 2007 and
therefore only used the data sets from these 4 years rather
than the 7 years. The datawere listed in the file byworld region
(i.e., Europe, Asia, Oceania, Africa, North America, and Latin
America) and sorted by the number of isolates of the serovar in
countries and by year. Israel was included the European region
due to its proximity to the European region and similar living
habits as opposed to Asian region, which mostly include
Southeast Asian countries. In general, only a limited number of
countries/regions have compulsory Salmonella reporting re-
quirements such as Member States in Europe, including Ice-
land, Norway, Switzerland, the Pan American region,
Thailand, Japan, NewZealand, South Africa, the United States,
and Canada (www.antimicrobialresistance.dk). For this study,
only results of the top 20 most frequent serovars per region
were included (Tables 1–6).
Descriptive analyses
Descriptive analyses, at the national and regional level, of
the proportion of serovars were performed, based on the data
reported by the countries/institutions.
Further descriptive analysis on the observed differences in
serovar distribution was performed using classifications
provided by the International Monetary Fund (www.imf
.org/external/index.htm). Population data were retrieved
from the Central Intelligence Agency (www.cia.gov/library/
publications/the-world-factbook/index.html). These sources
were used to classify the countries as developed (Australia,
Canada, Denmark, Finland, Germany, Greece, Israel, Italy,
Japan, Luxembourg, Malta, The Netherlands, New Zealand,
Spain, and the United States) or developing (all other par-
ticipating countries). SAS Enterprise Guide 3.0 (SAS Institute)
was used for data handling and Microsoft Excel (Microsoft
Corp), to plot the figures.
Results
Content of the data set
The final data set extracted from the CDB and included
in this article originated from 37 countries (Public Health
Laboratories) within six regions. Out of the 37 countries, 31
submitted a national data set from a national reference labo-
ratory. For Cameroon, Malaysia, Belarus, Croatia, Germany,
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Table 1. Distribution of the 20 Most Frequently Serotyped Human Salmonella Isolates
from African Countries in Numbers and Percentages
Cameroona Senegal Tunisia
Population 18,467,692 12,853,259 10,383,577
Year 2001 2003 2005 2007 2001 2003 2005 2007 2001 2003 2005 2007
Total serotyped 242 182 151 99 232 176 151 102 720 599 363 243
Serotypes among top 20
in the region (%)
98.8 87.2 69.5 55.6 42.2 57.4 44.2 29.4 86.8 79.5 94.4 89.3
Enteritidis 20.7 14.8 21.2 19.2 19.8 8.0 19.2 4.9 14.3 27.9 28.1 49.0
Typhimurium 71.9 53.3 28.5 18.2 4.3 5.1 10.8 4.0 7.4 11.5
Livingstone 21.1 26.7 5.5
Corvallis 1.7 2.6 14.0 3.5 6.1
Typhi 5.4 17.0 18.5 16.2 7.8 8.5 7.9 4.9 2.1
Braenderup 1.0 13.1 3.6
Anatum 4.3 3.2 11.0 4.9
Infantis 0.5 5.7 10.2 1.6
Kentucky 6.0 9.7 4.0 3.9 2.8 6.2
Cerro 4.3 3.2 1.1
Newport 2.5 2.7 5.2
Mbandaka 0.8 2.0 5.3 2.8
Amsterdam 3.0 3.3 6.6
Hadar 1.6 1.3 1.0 4.3 1.7 2.6 2.9 2.5
Tokoin 17.6
Zanzibar 4.1 4.1
Altona 4.1 2.1
Muenster 1.1 2.6 1.9 1.2
Wien 2.2
Bredeney 4.0 5.3
aInstitutional data.
Table 2. Distribution of the 20 Most Frequently Serotyped Human Salmonella Isolates
from Asian Countries in Numbers and Percentages
Japan Republic of Korea Malaysiaa Philippines Thailand
Population 127,288,416 48,379,392 25,274,132 96,061,680 65,493,296
Year 2001 2003 2005 2007 2001 2003 2003 2005 2007 2005 2007 2001 2003 2005 2007
Total serotyped 2864 2422 1529 963 1037 676 929 1396 859 203 172 4134 3426 3669 2720
Serotypes among top
20 in the region (%)
77.2 80.7 68.5 72.8 76.1 65 90 94.5 80.6 89.7 96 74.4 70.9 67 77.5
Enteritidis 52.7 59.2 47.4 44.7 42.9 33.7 21.2 21.9 34.7 3.9 5.8 8.6 11.5 11 16.5
Weltevreden 15.5 13.5 17.1 0.5 0.6 15.9 11.1 9 6.1
Typhi 14 11.2 36.5 46 9.9 78.8 86.6
Stanley 1.2 1.5 1.1 2 1 5.9 8.6 12.4 10.9
Typhimurium 4.4 7.5 4.1 6.9 13.9 16 4.2 3.5 6.1 1.5 1.2 4.2 2.6 7.4
Rissen 1.5 1.8 0.4 6.3 6.4 8.9 8.1
Anatum 1.2 8.2 6.4 4.8 4.5
Corvallis 1.7 0.8 9.3 6.3 9.1 3.9 5.7 4.6
I 1,4,5,12:i:- 1.6 8.1 2.5 2.2 3.6
Choleraesuis 3 0.6 3.4 4.8 7.8
Panama 3.9 2.9 1.6 2.6
Virchow 1.3 1.9 1 0.4 0.5 2.5 2.4 2.3
Infantis 3.9 4.4 5.2 5.5 0.7
Albany 0.9 0.8 0.7 2.4 2.9 1.7 1.4
Thompson 5.5 2.2 4 5.9
Hadar 2 1 3.3 2.9
Agona 1.9 2.1 1.5 1 0.4 0.9 0.9 0.6 1 2.2 1.4
Derby 1.3 0.5 2.7 2 2.6
Saintpaul 3.8 2.6 2.2 6
Schwarzengrund 0.8 3.4 0.7 2.4 1.8
aInstitutional data.
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and Malta, where data were not submitted from a national
reference laboratory, we included data from an institute that
met the quality standard threshold of the EQAS.
Data from an additional 38 laboratories from 35 countries
that participated in one or more EQAS iterations were ex-
cluded from analysis for the following reasons: the laboratory
failed to meet the quality threshold of the EQAS (18 labora-
tories) (i.e., > 1/8 deviations from the expected results), the
laboratory uploaded institutional data, but national datawere
available and included (8 laboratories), or because the labo-
ratory did not submit data of human origin (12 laboratories).
During the study years 2001–2007, the number of countries
in this subset of the CDB submitting data which differed per
year, with 33 countries submitting data in 2001, 34 in 2003, 22
in 2005, and 19 in 2007.
The average number of isolates serotyped per 100,000 in-
habitants per region in all years fluctuated from 3.5 in the
Latin American region to 82.4 in the Oceania region. How-
ever, the average number of isolates serotyped per 100,000
inhabitants by all countries decreased over the years from 9.1
in 2001 to 1.9 in 2007.
A large variation in the number of serovars was observed at
the regional level. Salmonella serovars Enteritidis and Typhi-
murium were reported among the top 15 most common ser-
ovars in all regions. However, the number of additional
serovars that were present in the top 15 most commonly re-
ported differed from region to region with 90 serovars in the
European region, 20 in North American, 29 in Oceania region,
71 in Africa, 57 in Latin American, and 52 in the Asian region.
Potentially, these numbersmight be affected by the number of
countries submitting data form each region.
For Salmonella serovars Enteritidis and Typhimurium,
the proportions reported by each country were plotted by
region. A trend line was drawn on these plots over years
(Figs. 1 and 2). In the following step, proportions were esti-
mated at the country development level, grouping all the
participating countries into developing and developed
countries. Trends over the years were plotted, again dem-
onstrating differences in the proportion trends among the
evaluated groups (Fig. 3).
Salmonella serovars Enteritidis and Typhimurium
In all regions, with the exception of the Oceania andNorth
American regions, Salmonella serovars Enteritidis and Ty-
phimurium ranked as the most common and second most
common serovar, respectively. In the North American and
the Oceania regions, Salmonella serovar Typhimurium was
the most common serovar reported, and Salmonella serovar
Enteritidis was the second most common serovar (Tables 4
and 5).
Globally, the overall proportion of Salmonella serovar
Enteritidis and Typhimurium was 43.5% and 17.1% with
Salmonella serovar Enteritidis ranging from 40.6% in 2005 to
44.9% in 2003 and Salmonella serovar Typhimurium ranging
from 15% in 2007 to 18.9% in 2001 (Fig. 4). We observed an
overall decrease in the proportion of Salmonella serovar
Enteritidis in developing countries from 73.9% in 2001 to 55%
Table 4. Distribution of the 20 Most Frequently
Serotyped Human Salmonella Isolates from North
American Countries in Numbers and Percentages
Canada United States
Population 33,212,696 303,824,640
Year 2001 2003 2007 2001 2003 2005
Total serotyped 6359 5531 6455 31,675 31,484 33,348
Serotypes among top
20 in the region (%)
76.9 76.6 79.5 74.3 78.9 75.4
Typhimurium 21 20 20.8 22.1 21.1 20.9
Enteritidis 21.5 12.5 25.7 17.7 15.4 20.2
Newport 2.3 3.3 2.2 10 12.2 9.9
Heidelberg 13.9 19.9 8.7 5.9 5.7 5.7
Javiana 1.2 3.4 5.3 4
Montevideo 0.8 2 2.7 2.4
Saintpaul 1.5 2 1.9 1.5 2.6 2
Muenchen 1.3 1.8 2.5 2.2
Thompson 3.7 2.6 2.7 1.6 1.6 1.3
Oranienburg 1.7 2.2 1.9 1.8 1.8
Infantis 1.9 2.2 2 1.4 1.7 1.5
Braenderup 1.2 1.7 1.8
Agona 1.9 2.6 1.7 1.2 1.6
Mississippi 1.4 1.7
I 1,4,5,12:i:- 1.5 2.9 1.6
Typhi 1.8 2.4 2.4 1.1
Paratyphi B var. Java 1 1.3 1.5
Hadar 3.9 3.4 2.2
Stanley 1.7 1.3
Paratyphi A 1.5
Table 5. Distribution of the 20 Most Frequently
Serotyped Human Salmonella Isolates from Oceania
Countries in Numbers and Percentages
Australia New Zealand
Population 21,007,310 4,173,460
Year 2001 2003 2001 2003 2005 2007
Total serotyped 6932 6808 2605 1601 1460 1341
Serotypes among top
20 in the region (%)
75.9 68.7 86.7 87.7 81.5 79.7
Typhimurium 44.5 41.5 64 59.5 51.8 44.4
Enteritidis 4.4 3.4 6.5 8.6 10.3 11.3
Virchow 7.1 5.1 1.2 1.1 2.5
Saintpaul 5.5 4.4 0.6 1.7 4.5 1.9
Infantis 3 2.8 5.6 4.6 6.4
Chester 2.6 3.2 2.8
Birkenhead 3.5 2.6
Brandenburg 5.3 3.4 4.7 3.5
Bovismorbificans 2.3 1.7
Muenchen 1.9 2
Hvittingfoss 2.2
Heidelberg 4.9 0.7
Aberdeen 1.9
Anatum 1.8
Typhi 1 1.1 1.9 3.8
I 1.4.5.12:d: 0.5 1.5 1.3
Mississippi 0.9 1.5 0.8
Thompson 0.6 0.6 1.1
Mbandaka 0.5 0.6 1
Montevideo 2.3
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in 2007 and an overall decrease in the proportion of Salmonella
serovar Typhimurium in developed countries from 26.4% in
2001 to 18.8% in 2007 (Fig. 3). Further, the changes in pro-
portions differed between regions and countries, where the
distribution of serovar proportion of Salmonella serovar En-
teritidis presented an increase in Africa (16.7% in 2001 to
32.2% in 2007), Oceania (5% in 2001 to 11.3% in 2007), and the
North America (18.4% in 2001 to 25.7% in 2007). In Europe,
the proportion of Salmonella Enteritidis increased until 2005
(from 66.3% in 2001 to 75.7% in 2005), but decreased in 2007
(60.9%) (Fig. 1). Salmonella serovar Typhimurium increased in
Latin America (14.5% in 2001 to 24% in 2007), but decreased in
all other regions (Fig. 2). In Asia, the Salmonella serovar Ty-
phimurium decreasing trend between 2001 and 2005 (from
5.5% to 3.1%) was followed by an increase in 2007 (6.8%).
The changes were not equally distributed between coun-
tries within the same region. Thus, the increase of Salmonella
serovar Enteritidis in Africa was due to a major increase of
this serovar in Tunisia, and the decrease of Salmonella serovar
Typhimuriumwasmainly due to a decrease of this serovar in
Cameroon (Table 1). Similarly, the decrease of Salmonella
serovar Enteritidis in Asia was due to decreases in Japan and
Korea (Table 2). Salmonella serovar Enteritidis increased in three
countries of Latin America, but decreased in four (Table 6).
Salmonella serovar Typhi
An increase in the proportion of Salmonella serovar Typhi in
all regions combined was initially observed in 2003. Since
2003, the overall proportion of Salmonella serovar Typhi has
increased from 0.7% 2001 to 2.2% 2007 (Fig. 4). This increase
was observed in both developed countries, mainly driven by
New Zealand, and developing countries, during the studied
period (Fig. 3).
In the Oceania region, Salmonella serovar Typhi was the
15th most common serovar reported to the CDB (Table 5). A
similar level was also observed in the North American region,
being mainly represented by Canada (Table 4). In the African
region, Salmonella serovar Typhi was ranked as the fifth most
common serovar. In Senegal, Salmonella serovar Typhi de-
creased from 7.8% in 2001 to 4.9% in 2007 (Table 1), whereas
in Cameroon, the proportion of Salmonella serovar Typhi
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FIG. 1. Distribution of Salmonella Enteritidis proportions and trends between 2001 and 2007, by region, based on data
submitted by 37 selected countries.
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increased from 5.4% (2001) to 16.2% (2007) and was first re-
ported in Tunisia among the top 15 in 2007 (Table 1).
All countries in the Latin American region, with the ex-
ception of Costa Rica, Paraguay, and Uruguay, reported Sal-
monella serovar Typhi among the top 15 most common
serovars nationally. In Brazil and Chile, the proportion de-
creased from 9.7% in 2001 to 3% in 2007 and from 15.4% in
2001 to 4.1% in 2007, respectively, whereas the proportion
increased in Colombia from 2.1% in 2001 to 12.2% in 2007
(Table 6). In the Asian region, Salmonella serovar Typhi was
the third most common serovar reported by the Republic of
Korea and the most common serovar reported by Malaysia
and the Philippines (Table 2). In the European region, Sal-
monella serovar Typhi was, in general, listed only as the 35th
most common serovar (data not shown).
Other nontyphoidal Salmonella serovars
In addition to Salmonella serovars Enteritidis and Typhi-
murium, Salmonella serovar Infantis was also among the ser-
ovars reported from all regions (Tables 1–6). Globally, the
overall proportion of Salmonella serovar Infantis ranged over
the years, from 1.5% to 2.2% (Fig. 4). The increase was mainly
associated with the developed regions (Fig. 3). The serovar
was ranked as the fifth most common serovar in the European
region (Tables 3a and 3b).
Salmonella serovar Agona was frequently observed in Latin
America, ranking among the top three most common non-
typhoidal serovars. This serovar was also ranked 7th in Eur-
ope and 13th in North America (Tables 3a, 3b, and 4). Overall,
the proportion of this serovar changed from 0.8% to 1.5%
between 2001 and 2007. This increase was observed in both
developed and developing countries, and was accentuated
between 2005 and 2007 (Fig. 3).
Heidelberg was much more common among developed
countries and ranked 4th in North America, whereas lower
frequencies were seen in Europe (9th) and Latin America
(19th) (Tables 3, 4, and 6). It is noteworthy that Salmonella
serovar Heidelberg was not found among the 20 most com-
mon serovars in the African and Asian region.
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FIG. 2. Distribution of Salmonella Typhimurium proportions and trends between 2001 and 2007, by region, based on data
submitted by 37 selected countries.
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Salmonella serovar Virchow was only reported among the
top serovars in Asia, Europe, and the Oceania regions.
However, in these regions, Salmonella serovar Virchow often
represented a high proportion of the Salmonellae isolated from
countries (Tables 2, 3, and 5). The overall proportion of this
serovar has fluctuated over the years (Fig. 4) and since 2005,
an increase, mainly driven by Israel and New Zealand, has
been seen among developed countries with proportional de-
crease reported by developing countries (Fig. 3).
High frequencies of Salmonella serovar Thompson were
seen in Europe and North America (Tables 3 and 4). Ad-
ditionally, Salmonella serovar Newport has consistently been
reported among the top six serovars by the North American,
European, and Latin American regions. Nevertheless, the
overall proportion of Salmonella serovar Newport, increased
from 3% in 2001 to 5% in 2005, but showed a decrease in 2007
(1.2%) (Fig. 4). Salmonella serovar Oranienburg was only ob-
served in North and Latin America and was reported as the
10th and 15th most common serovar, respectively (Tables 4
and 6).
Salmonella serovar Hadar and Salmonella serovar Mon-
tevideo were reported by almost all regions. However, the
FIG. 3. Trends of serovars between 2001 and 2007, by country development status.
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frequencies varied considerably. Salmonella serovar Hadar was
observed among the top three serovars in Europe, but was seen
at lower frequencies in other regions (Tables 3a and 3b). Finally,
Salmonella serovar Montevideo was more common in North
and Latin America (the United States, Argentina, and Chile),
whereas Salmonella serovar Saintpaul was more predominant
in Oceania and North America (Tables 4–6).
Discussion
The data presented in this study are the first attempt to
establishing a global monitoring based on quality-assured
data of the occurrence of Salmonella infections in humans. In
general, the highlighted serovars among humans presented
by Galanis et al. (2006), based on nonselected data available in
the CDB between 2000 and 2002, seem to be in agreementwith
the data from this study submitted by laboratories that per-
form at or above the quality standard threshold of the EQAS.
This observation suggests that the majority of the human data
in the CDB could be regarded as valid and therefore be in-
cluded in future analysis of aggregated data. However, as the
EQAS results of individual laboratories are confidential, the
general user of the CDB data cannot assess the validity of data
provided by a single source. Therefore, care should be taken
when interpreting results from direct comparisons between
single countries, especially when these are geographically
distinct and have no links through travel or trade.
In this study, the data provide microbiologists and epide-
miologists with a unique tool to understand the epidemiology
of Salmonellaworldwide in humans. Today,we are all residents
of a global village; with the increased trade of food, animal
feed, and livestock, as well as increased travel and human
migration, infectious disease is no longer confined to a single
country. The data presented in this study reveal the complexity
of global epidemiology, particularly as frequency and occur-
rence change over time in countries and regions. Epidemiolo-
gists may gain valuable knowledge for outbreak detection and
hypothesis generation regarding the origin of the infections by
knowing which serovars predominate in which regions. This
information may lead an investigation to a specific country to
which patients have traveled or to where a certain food source
originates. This quality-assured monitoring data can also serve
as a tool for launching targeting interventions to diminish the
burden of salmonellosis caused by specific serovars since lim-
ited surveillance data are public available. The data reveal that
developing regions may harbor a potentially broader serovar
spectrum to foster new emerging serovars that could be critical
for global food safety. This may require food safety authorities
to take alternative actions in implementing intervention and
control programs in reservoirs of specific predominant Salmo-
nella serovars. This could, for instance, be a targeted early ac-
tion to decrease the frequency of Salmonella serovar Typhi in a
specific region or against Salmonella serovar Infantis, which are
increasing heavily in Europe (Anonymous, 2007d). Further, it is
necessary to encourage foodandveterinary institutes to upload
additional data to the CDB, which might reveal linkages be-
tween human illness and the different reservoirs of the Salmo-
nella serovars.
There were major differences among the most commonly
isolated serovars between regions, but fewer differences
FIG. 4. Overall distribution of specific Salmonella serovar proportions in 37 selected countries over time.
GLOBAL MONITORING OF SALMONELLA 11
between countries within the same region. In addition, we
observed major differences between countries and regions in
serovars detected by year, and we believe that several pa-
rameters may have influenced these differences. In developed
countries, the production of food animals are limited to the
most common species/breeds and the production systems are
often effective and high scale (Swanson, 1995). In addition, the
production stock commonly stems from highly centralized
rearing facilities. This has a great potential for spread of one or
more Salmonella serovars to a large number of herds and
flocks, as was demonstrated by the Salmonella serovar En-
teritidis pandemic throughout the 1990s, which affected both
developed and developing countries. In developing countries,
the production scale is normally not intensive. In addition,
developing countries in tropical regions typically raise native
crops and animals that are then consumed locally. This locally
produced food may harbor a greater diversity of less com-
monly reported serovars.
There are many potential reasons why the proportion of
isolates serotyped may differ between countries. An apparent
reasonmay be due to geographical, cultural, or socioeconomic
factors in-country that limit the population’s access tomedical
care; limited access to laboratory testing; or a truly low pro-
portion of serotyped Salmonella in these countries due to a low
number of human cases. In contrast, a high proportion of
isolates serotyped may be due to a national outbreak in a
specific year or time period. The CDB does not gather this
information when representatives submit data from their
countries. The proportion of serotyped isolates is certainly
also influenced by active surveillance programs that are in
place in several countries. Potentially, there might be huge
variations in the surveillance systems between the countries
including when isolates are forwarded to the national refer-
ence laboratory. Therefore, the representativeness of the data
at the national level is likely not the same in all countries, the
data from countries with few isolates likely being less reliable
than the ones from countries where many isolates are sub-
mitted. However, we believe this to have a minor effect on the
ranking of the serovars, as long as the data are captured from
a representative sample of the population.
Salmonella serovars Enteritidis and Typhimurium
Consistent with other compulsory Salmonella surveillance
reporting’s from New Zealand (Anonymous, 2007a), South
Africa (Anonymous, 2007c), the United States (Anonymous,
2008), Canada (Anonymous, 2007b), Europe (Anonymous,
2007d), and Thailand (Anonymous, 2006), our data revealed
that Salmonella serovar Enteritidis, followed by Salmonella
serovar Typhimurium, were the most frequently isolated
serovars from humans worldwide. This trend was also ob-
served in an article describing nonselected data from the CDB
in 2000–2002 (Galanis et al., 2006). Interestingly, despite some
fluctuations between countries, we observed a global decrease
in the proportion of Salmonella serovars Enteritidis and Ty-
phimurium. This decrease could be explained by the intense
focus worldwide on these particular serovars and the intro-
duction of specific monitoring and control programs.
Salmonella serovar Typhi
Salmonella serovar Typhi was by far the most commonly
reported of the typhoidal serovars and present among the top
20 most common serovars in almost all of the regions, in-
cluding both developing and developed countries. However,
specific countries—Argentina, Brazil, Chile, Columbia, Peru,
Philippines, and Malaysia—and regions—Latin America and
Southeast Asia—seem to be much more affected by this ser-
ovar than others. Our data correspondwell with the data from
the Pan American Health Organization showing that most of
the countries in this region have Salmonella serovar Typhi
ranked among the top five most common serotypes (Anon-
ymous, 2004). In endemic countries, typhoid fever is typically
associated with poor sanitation (Vollaard et al., 2004); in de-
veloped countries, most cases of typhoid occur in travelers
returning from developing countries (Steinberg et al., 2004).
While the epidemiology of typhoid varies by development
status, these data suggest that there is a need to increase
awareness and prevention measures of typhoidal Salmonella
in both developed and developing countries.
Other nontyphoidal Salmonella serovars
A few serovars predominate worldwide, which we be-
lieve to be caused mainly by central rearing of production
animals, international trade of food, animal feed and live-
stock, and travel. It was not possible to test these hypotheses
within the scope of these data, but several publications/
surveillance reports support the observation that serovars
follow trade patterns. For example, a recent outbreak in the
United States was caused by Salmonella serovar Saintpaul,
which originated from imported jalapenos peppers from
Mexico [Centers for Disease Control and Prevention (CDC,
2008)]. In 2004, several countries in Europe also observed a
regional outbreak caused by Salmonella serovar Thompson in
rucola lettuce originating from one producer in Italy (Ny-
ga˚rd et al., 2008). Data from recent studies have also identi-
fied indistinguishable pulsed-field gel electrophoresis
patterns of Salmonella serovar Schwarzengrund from pa-
tients in Denmark, the United States, and Thailand and
chicken meat originating from Thailand (Aarestrup et al.,
2007). Similarly, identical clones of Salmonella serovar Rissen
were found among Thai patients and Danish patients with a
history of travel to Thailand (Hendriksen et al., 2008). Source
attribution data from Denmark also support that trade and
international travel play a major role in the transmission of
Salmonella (Hald et al., 2007).
It is noteworthy that while Salmonella serovars Enteritidis
and Typhimurim decreased during the observational period,
a number of other serovars such as Salmonella serovars Typhi,
Infantis, and Virchow increased in relative importance. This is
also in agreement with what have been observed in many
other countries/regions such as in Europe (Anonymous,
2007d) and New Zealand (Anonymous, 2007a). This could
indicate that some of the control measures taken against Sal-
monella serovars Enteritidis and Typhimurium are not equally
efficient against other serovars, or that other sources that act
as reservoirs for these serovars have become increasingly
important (e.g., unconventional food animal species, wild or
free-range domestic animals). Therefore, we may have to
develop and implement novel control strategies for these
serovars. To determine the sources toward which control
programs should be initiated, as well as to determine the
impact of the programs in place, there is a continuing need for
national, regional, and global monitoring.
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The data set and limitations
This study is based on reported data from 37 countries. This
only represents about 20% of all WHO Member States. We
observed huge differences between the representativeness of
the data from different regions: Asia was represented by five
countries, of which the two largest (China and India) were not
being represented; Africa was represented by only three
countries, and North America and Oceania by two countries
each. Together with the irregular reporting performed by
some countries, providing data only for some of the evaluated
years, this could affect the overall interpretation of the results.
One would also expect higher degrees of participation from
developed countries such as in Europe, where resources for
isolation, identification, and serotyping of Salmonella to a large
extend are available. The reasonwhy only a limited number of
countries from Europe have been included in this study was
not because of them not qualifying.We believe that the reason
is that in Europe, the monitoring of Salmonella offered by the
European Union is mandatory (Anonymous, 2007d). Many
European countries see no reason to participate/submit data
to two surveillance systems. Despite the lack of participation
from European countries, our results correspond well with
the data collected annually by the European Food Safety
Authority (Anonymous, 2007d).
Salmonella serovar Typhi is endemic in many developing
countries, that is, countries with weaker health-care systems
than industrialized countries. In such countries, we would
expect the chance of getting diagnosed (and the disease
reported) with typhoid fever is much higher than for nonin-
vasive serotypes. In this study, it might result in an over-
representation of this invasive serovar why it should be
interpreted with care.
In the period 2001–2007, only data from every second year
were included in the study for easy of analysis and interpre-
tation. Despite the fact that some geographical regions are
represented by a limited number of countries and only data of
every second year were included, we assume that the data are
broad enough and of sufficient quality to describe global
trends in Salmonella serovar distribution.
Institutional data from Cameroon, Malaysia, Belarus,
Croatia, Germany, andMalta were included to obtain a better
coverage of countries in the regions (Tables 1–6). For some
countries, national data submitted by the national reference
laboratory might have also included data collected from other
institutes that may or may not have been participating in the
EQAS program. Consequently, the validity of these data is not
entirely known, but is expected to be high, based on the skills
and quality of the national reference laboratories.
The data sets in the CDB are limited to the proportion of the
top 15 most commonly found serovars and the total number
of samples serotyped per country and per year. Due to this
limitation not all serovars isolated in a specific country are
included, for example, top 15 most common serovar ob-
served. This limitation also results in a limitation in the
summary of the regional top 20. WHO GFN has as a result of
this limitation decided to expand the CDB to in the future to
cover all serovars reported by the respective countries.
In general, we observed a decreasing number of isolates
being serotyped and the number of isolates available for the
analysis was variable and being very small in some countries.
It is generally recognized that salmonellosis is not decreasing
at the global level. However, we do not know if this reflects a
global decrease in national funds available for this area of
public health care, or fewer countries reporting to the CDB. It
is a problem that the number of countries providing data to
the analysis decreased over time why WHO GFN needs to
encourage participants to ensure a more timely submission of
data. The same delay in reporting surveillance data has also
been observed in European surveillance program where the
notification rates decreased from *44% in 2004 to *33% in
2007 (Anonymous, 2007d).
The CDB was designed to be a self-updating database
where the designatedmembers are responsible for populating
the database. However, the submission of data to the CDB is
voluntary, and the task is not always automatically trans-
ferred to a successor when a designated member institution
representative leaves the post.
Conclusion
The outcome of this study shows large differences in the top
20 most commonly isolated serovars between regions, but
lesser differences between the top 15 most commonly isolated
serovars between countries within the same region. Noting
this, a few serovars are more frequent than others in many of
the regions and countries. Additionally, we observed that the
consistency with which serovars were reported by the coun-
tries varied by both region and development status. In general,
the serovar spectrum and serovar distribution reported by
developed countries remained relatively consistent over the
years in comparison with what was observed in developing
countries, showing considerable year-to-year variability in
both the serovar spectrum and serovar distribution. Our
findings highlight the complexity of the global epidemiology of
Salmonella and the urgent need and importance for improving
monitoring data of those serovars of highest epidemiologic
importance and initiate early actions to control further spread
of those serovars. We also advise carefully monitoring some
serovars on a global level, such as Salmonella serovars Infantis,
Hadar, Newport, Virchow, and Agona. In addition, the data
show a decreasing tendency to isolate and serotype in the
countries included this study. This is a concerning trend as
isolates and the subtype data obtained from them are the
cornerstone of laboratory-based surveillance systems for
Salmonella. We encourage laboratories to work with their clin-
ical counterparts to increase the number of samples submitted
for culture and serotyping. We also stress the use of quality
methods and the timely reporting of data to national surveil-
lance networks. The effect of using quality-assured data, based
on EQAS participation, was minor, but we recommend using
aggregate data in contrast to data originating from single
institutes. The data presented in this study may guide the
development of regional and serovar-specific intervention and
control programs. As such, we urge food and veterinary in-
stitutes to upload the data on the 15 most commonly isolated
Salmonella serovars to the CDB. Nonhuman data are essential
to the CDB; these data, when supplemented with human
clinical data, can help to identify important reservoirs and help
initiate longer-term prevention and control measures.
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